NexGel Inc NXGL
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if NXGL is a good fit for your portfolio.
News
-
NEXGEL to Present at the Planet MicroCap Showcase: VEGAS 2024, May 1 & 2, 2024
-
NEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an Increase of 99.7% Year-Over-Year
-
Thinking about buying stock in Ibio, Village Farms International, MariaDB, Nexgel, or Urban Outfitters ?
-
NEXGEL Reschedules Fourth Quarter and Full Year 2023 Financial Results Conference Call to Monday, April 1st at 8:30 a.m. ET Due to Holiday
-
NEXGEL to Report Fourth Quarter and Full Year 2023 Financial Results on March 28th
-
RETRANSMISSION: iAccess Alpha's Buyside Best Ideas Spring Virtual Conference March 12th and 13th, 2024
-
NEXGEL to Present at the iAccess Alpha Best Ideas Spring Virtual Conference on March 12th
-
NEXGEL Announces $975,000 Registered Direct Offering Led by Insiders
Trading Information
- Previous Close Price
- $2.21
- Day Range
- $2.14–2.15
- 52-Week Range
- $1.40–3.14
- Bid/Ask
- $2.15 / $2.27
- Market Cap
- $13.39 Mil
- Volume/Avg
- 784 / 24,178
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 3.00
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating, and cross-linking technologies.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Growth
- Total Number of Employees
- 19
- Website
- https://www.nexgel.com
Valuation
|
Metric
|
NXGL
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 2.64 |
Price/Sales | 3.00 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
NXGL
|
|---|---|
Quick Ratio | 2.69 |
Current Ratio | 3.58 |
Interest Coverage | −175.80 |
Quick Ratio
NXGL
Profitability
|
Metric
|
NXGL
|
|---|---|
Return on Assets (Normalized) | −23.79% |
Return on Equity (Normalized) | −36.49% |
Return on Invested Capital (Normalized) | −26.45% |
Return on Assets
NXGL
Medical Instruments & Supplies Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ISRG
| Intuitive Surgical Inc | Sxwmxfzypc | Zdzn | $132.1 Bil | |
BDX
| Becton Dickinson & Co | Gkgmbzx | Pxqkxd | $67.4 Bil | |
ALC
| Alcon Inc | Fndhqqdc | Gvdcbj | $39.1 Bil | |
CLPBY
| Coloplast A/S ADR | Lgfsxyypv | Yvx | $28.8 Bil | |
WST
| West Pharmaceutical Services Inc | Qpvkfbzdr | Mgtv | $27.6 Bil | |
RMD
| ResMed Inc | Nzdbxffm | Trhpyk | $26.1 Bil | |
BAX
| Baxter International Inc | Zynlnlmf | Nwnzq | $20.1 Bil | |
COO
| The Cooper Companies Inc | Vpxxjdd | Bxcvrgq | $18.0 Bil | |
HOLX
| Hologic Inc | Lyhmrndz | Wqmvgc | $17.6 Bil | |
TFX
| Teleflex Inc | Hprs | Bwf | $9.8 Bil |